VEGFR2 Kinase Inhibitor III CAS: 204005-46-9
MF: C15H14N2O
MW: 238.28
A VEGFR2, Met, RET, PDGFR, and ALK inhibitor.

VEGFR2 Kinase Inhibitor III (CAS 204005-46-9)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 134ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
VEGFR2 Kinase Inhibitor III is rated 5.0 out of 5 by 1.
5
1
4
0
3
0
2
0
1
0
Alternativa namn: Semaxanib; SU 5416
Ansökan VEGFR2 Kinase Inhibitor III is a VEGFR2, Met, RET, PDGFR, and ALK inhibitor
Momsregistreringsnummer :: 204005-46-9
Purity: ≥97%
Molecular Weight: 238.28
Molecular Formula: C15H14N2O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

VEGFR2 Kinase Inhibitor III is a cell-permeable ATP-competitive inhibitor of Flk-1 (VEGFR2/KDR, kinase insert domain receptor), which is the major growth factor for vascular endothelial cells. This receptor is a type III tyrosine kinase receptor that functions as the main mediator of VEGF-induced endothelial proliferation, survival, and migration. Studies suggest that VEGFR2 Kinase Inhibitor III also inhibits a variety of other receptors such as Met, Flt-3/Flk-2 (FLT-3 receptor tyrosine kinases), Ret, c-Kit, PDGFR, c-Abl and Arg (ABL), and ALK. In addition, VEGFR2 kinase inhibitor III regulates the signaling pathways used by oncogenic RET-transfected cells by regulating the extracellular signal regulated kinase (ERK) and JNK pathways.


Konferenser

1. Vajkoczy, P., et al. 1999. Neoplasia. 1: 31-41. PMID: 10935468
2. Mologni, L., et al. 2006. J. Mol. Endocrinol. 37: 199-212. PMID: 17032739
3. Komi, Y., et al. 2009. Cancer Sci. 100: 269-277. PMID: 19200258

Physical State :
Solid
Solubility :
Soluble in DMSO (5 mg/ml), and ethanol (100 mM). Insoluble in water.
LAGRING :
Store at 4° C
Melting Point :
221-222° C
Boiling Point :
481.41° C at 760 mmHg (Predicted)
Density :
1.26 g/cm3 (Predicted)
Refractive Index :
n20D 1.68 (Predicted)
IC50 :
proliferation of HUVEC50s induced by VEGF: IC50 = 50 nM; autophosphorylation of internal tandem duplication: IC50 = 0.1 µM; autophosphorylation of wild type Fms-like tyrosine kinase 3: IC50 = 0.1 µM; VEGF-R: IC50 = 1.04 µM (NIH 3T3 cells overexpressing Flk-1); Oxytocin-R: EC5050 = 11.47 µM (human); AVP Receptor V1a: EC5050 = 12.07 µM (human); PDGF-R tyrosine kinases: IC50 = 20 µM (NIH 3T3 cells overexpressing Flk-1); proliferation of HUVEC50s induced by EC50GS: IC50 = 30.5 µM; proliferation of HUVEC50s induced by bFGF: IC50 = 5.3 µM
pK Values :
pKa: 13.18 (Predicted), pKb: 1.53 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
PubChem CID :
5329098
MDL Number :
MFCD01940922
SMILES :
CC1=CC(=C(N1)/C=C\\2/C3=CC=CC=C3NC2=O)C

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

VEGFR2 Kinase Inhibitor III (CAS 204005-46-9)  Produkt Citat

See how others have used VEGFR2 Kinase Inhibitor III (CAS 204005-46-9). Click on the entry to view the PubMed entry .

Citations 1 to 5 of 5 total

PMID: # 26699078  Giordano, A. et al. 2016. Vascul. Pharmacol. 80: 67-74.

PMID: # 25450973  Lahiani, A. et al. 2015. Biochim. Biophys. Acta. 1853: 422-30.

PMID: # 25886469  Cui, HJ. et al. 2015. BMC Complement Altern Med. 15: 91.

PMID: # 30028964  Chem Biol Interact. 110-120.

PMID: # 24751361  Giordano, A. et al. Vascul. Pharmacol. 61: 63-71.

Citations 1 to 5 of 5 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 116ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 6ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.